Somnomed finds UK distribution partner
Tuesday, 08 July, 2008
Somnomed [ASX: SOM] has appointed Intus Healthcare as the company's distribution partner for the UK market.
Intus will distribute Somnomed's dental Mandibular Advancement Splint (MAS) device for sleep apnea and snoring therapy device to the market.
The UK is generally considered to be one of the most important sleep therapy markets in Europe.
Intus is a major supplier of sleep therapy products, and is headquartered on the outskirts of London.
NSW Govt delivers foot-and-mouth vaccine to protect livestock
A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as...
Scientists optimise delivery of mRNA to target cells
A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded...
'Anti-reward' brain network helps explain cocaine addiction
A new study identifies a specific 'anti-reward' network deep in the brain that undergoes...